Group by Gene: Chemotherapy Immunotherapy Interleukins DNA BCL Inhibitors Proteasome Inhibitors Serine-Threonine Kinase Inhibitors CD Protein Inhibitors Immune Checkpoint Inhibitors | Proteasome inhibitor bortezomib | Topoisomerase II inhibitor pegylated liposomal doxorubicin | Tubulin polymerization inhibitor vinorelbine tartrate | DNA synthesis inhibitor gemcitabine | Bcl2 inhibitor, Tubulin inhibitor albumin-bound paclitaxel | Topoisomerase II inhibitor, DNA inhibitor etoposide oral | mTOR inhibitor sirolimus | TNF inhibitor thalidomide | PD1 inhibitor pembrolizumab | TNFα inhibitor, IL-12 inhibitor, IL-6 inhibitor lenalidomide | Tubulin polymerization promoter, Bcl2 inhibitor paclitaxel | TNFα inhibitor, IL-1β inhibitor, IL-10 stimulant, NK cell stimulant, IL-6 inhibitor pomalidomide |
---|---|---|---|---|---|---|---|---|---|---|---|---|
No biomarker | ||||||||||||
PD-L1 expression |